Literature DB >> 311781

Immunoregulation in humans: control of antitetanus toxoid antibody production after booster immunization.

R H Stevens, A Saxon.   

Abstract

Booster immunization of normal individuals with soluble tetanus toxoid resulted in the ability of the individuals' peripheral blood lymphocytes to synthesize immunoglobulin (Ig)G antitetanus toxoid antibody in vitro when stimulated by pokeweed mitogen. The capacity for this in vitro antitetanus toxoid antibody response developed within 14 days after booster immunization, reached a peak between days 36--50, and disappeared by day 60. The inability of pokeweed mitogen to stimulate antitetanus toxoid antibody synthesis in vitro before booster immunization was not due to excess suppression by thymus-derived (T) lymphocytes but reflected insufficient numbers of functionally specific helper T lymphocytes and bone marrow-derived (B) lymphocytes. Antigen-specific T-lymphocyte suppression and decreased B-lymphocyte function were associated with the observed reduction of in vitro synthesis of antitetanus toxoid antibody from 20--60 days post-immunization. The in vitro kinetics of antitetanus toxoid antibody synthesis paralleled the synthesis of total IgG in that stimulation by pokeweed mitogen was required and that antibody secretion into the medium initiated by day 4 and increased through day 9.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 311781      PMCID: PMC371879          DOI: 10.1172/JCI109234

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Glucocorticoids administered in vivo inhibit human suppressor T lymphocyte function and diminish B lymphocyte responsiveness in in vitro immunoglobulin synthesis.

Authors:  A Saxon; R H Stevens; S J Ramer; P J Clements; D T Yu
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

2.  The differential effect of in vivo hydrocortisone on the kinetics of subpopulations of human peripheral blood thymus-derived lymphocytes.

Authors:  B F Haynes; A S Fauci
Journal:  J Clin Invest       Date:  1978-03       Impact factor: 14.808

3.  Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells.

Authors:  S Broder; D Poplack; J Whang-Peng; M Durm; C Goldman; L Muul; T A Waldmann
Journal:  N Engl J Med       Date:  1978-01-12       Impact factor: 91.245

4.  Primary in vitro antibody response from human peripheral blood lymphocytes.

Authors:  J F Delfraissy; P Galanaud; J Dormont; C Wallon
Journal:  J Immunol       Date:  1977-02       Impact factor: 5.422

5.  Generation of human plaque-forming cells in culture: tissue distribution, antigenic and cellular requirements.

Authors:  E W Gelfand
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

6.  Induction of antigen-specific human suppressor T lymphocytes in vitro.

Authors:  F UytdeHaag; C J Heynen; R E Ballieux
Journal:  Nature       Date:  1978-02-09       Impact factor: 49.962

7.  Association between an HLA haplotype and low responsiveness to tetanus toxoid in man.

Authors:  T Sasazuki; Y Kohno; I Iwamoto; M Tanimura; S Naito
Journal:  Nature       Date:  1978-03-23       Impact factor: 49.962

8.  Single step separation of human T and B cells using AET treated srbc rosettes.

Authors:  A Saxon; J Feldhaus; R A Robins
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

9.  Studies on the pathogenesis of an immune defect in multiple myeloma.

Authors:  T Paglieroni; M R MacKenzie
Journal:  J Clin Invest       Date:  1977-06       Impact factor: 14.808

10.  Functional analysis of two human T-cell subpopulations: help and suppression of B-cell responses by T cells bearing receptors for IgM or IgG.

Authors:  L Moretta; S R Webb; C E Grossi; P M Lydyard; M D Cooper
Journal:  J Exp Med       Date:  1977-07-01       Impact factor: 14.307

View more
  40 in total

1.  Limiting dilution analysis of specific in vitro anti-herpes simplex virus antibody production by human lymphocytes.

Authors:  M Yasukawa; Y Kobayashi
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

2.  The transfer of antigen-specific humoral immunity from marrow donors to marrow recipients.

Authors:  L G Lum; M C Seigneuret; R Storb
Journal:  J Clin Immunol       Date:  1986-09       Impact factor: 8.317

3.  In vitro induction of HBsAg-specific CD8 CD11 human suppressor T cells.

Authors:  V Barnaba; G Ruberti; M Levrero; F Balsano
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

4.  Specific suppression of anti-DNA production in vitro.

Authors:  M R Liebling; C Wong; J Radosevich; J S Louie
Journal:  J Clin Immunol       Date:  1988-09       Impact factor: 8.317

5.  Antibody to bacteriophage phi X 174 synthesized by cultured human peripheral blood lymphocytes.

Authors:  J Bohnsack; H D Ochs; R J Wedgwood; S R Heller
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

6.  Nature of immunological non-responsiveness to hepatitis B vaccine in healthy individuals.

Authors:  S S Chiou; K Yamauchi; T Nakanishi; H Obata
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

7.  Designed transfer of specific immune responses with bone marrow transplantation.

Authors:  A Saxon; R Mitsuyasu; R Stevens; R E Champlin; H Kimata; R P Gale
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

8.  Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.

Authors:  V Barnaba; G Valesini; M Levrero; C Zaccari; A Van Dyke; M Falco; A Musca; F Balsano
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

9.  Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation.

Authors:  M Benkerrou; D W Wara; M Elder; Y Dror; A Merino; B W Colombe; M Garovoy; M J Cowan
Journal:  J Clin Immunol       Date:  1994-03       Impact factor: 8.317

10.  12-O-Tetradecanoylphorbol-13-acetate (TPA) directly inhibits spontaneous immunoglobulin secretion by in vivo antigen-induced human lymphoblastoid B cells.

Authors:  J A Brieva; J S Louie; R H Stevens
Journal:  J Clin Immunol       Date:  1984-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.